|
|
|
Volumn 32, Issue SUPPL. 3, 1997, Pages 78-80
|
|
Innovative approaches to the hormonal treatment of advanced prostate cancer
|
|
Author keywords
Androgen ablation, maximal; Androgen blockade, sequential; Androgen suppression, intermittent; Prostate cancer, advanced
|
|
Indexed keywords
ANDROGEN;
ANDROGEN RECEPTOR;
ANDROSTANOLONE;
ANTIANDROGEN;
PROSTATE SPECIFIC ANTIGEN;
STEROID 5ALPHA REDUCTASE INHIBITOR;
STEROID HORMONE RECEPTOR BLOCKING AGENT;
TESTOSTERONE;
ADVANCED CANCER;
CANCER HORMONE THERAPY;
CASTRATION;
HUMAN;
IMPOTENCE;
LIBIDO;
MALAISE;
MALE;
MENTAL DISEASE;
MUSCLE ATROPHY;
PRIORITY JOURNAL;
PROSTATE CANCER;
SHORT SURVEY;
TESTOSTERONE BLOOD LEVEL;
TESTOSTERONE METABOLISM;
TUMOR REGRESSION;
ANDROGEN ANTAGONISTS;
ANTINEOPLASTIC AGENTS;
COMBINED MODALITY THERAPY;
CONTROLLED CLINICAL TRIALS;
DIHYDROTESTOSTERONE;
HUMANS;
MALE;
PALLIATIVE CARE;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
QUALITY OF LIFE;
RECEPTORS, ANDROGEN;
RISK ASSESSMENT;
TESTOSTERONE;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 0030768031
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (11)
|
|
References (6)
|
